The Covid emergency in the U.S. ends May 11. HHS officials say here’s what to expect

The Covid emergency in the U.S. ends May 11. HHS officials say here’s what to expect


People walk past a COVID-19 walk up testing site on July 28, 2022 in New York City.

Liao Pan | China News Service | Getty Images

The Health and Human Services Department on Thursday laid out what will change and will remain the same when the three-year-long Covid public health emergency ends in May.

Health Secretary Xavier Becerra officially informed the state governors on Thursday that he is renewing the declaration a final time but plans to let the emergency expire on May 11. The White House had already informed Congress of these plans last week.

HHS officials in call with reporters laid out what the the public can expect when the emergency ends.

Immediate changes:

  • People with private health insurance may have to pay for Covid tests, both over-the-counter and lab, depending on their plan.
  • Seniors with Medicare Part B will start paying for over-the-counter tests, though the program will cover lab tests.
  • Hospitals will lose flexibility to expand capacity in response to surges.
  • The federal government can no longer require labs to report Covid test results to the Centers for Disease Control and Prevention.

Longer-term changes

  • Covid vaccines and antivirals such as Paxlovid will remain free to everyone regardless of insurance status until the current federal stockpile runs out.
  • Expanded telehealth through Medicare will also remain in place through December 2024 under federal spending legislation passed in December. But it will end after that without congressional intervention.

The Food and Drug Administration will still have the authority to rapidly authorize Covid vaccines, tests and treatments through its separate emergency powers.

Millions of people are also at risk of losing health insurance through Medicaid this year as federal protections that kept people covered during the pandemic come to an end. These protections were once tied to the public health emergency, but Congress then decided to phase them out separately.

In short, states can start kicking people off Medicaid as early as April if they no longer meet eligibility requirements for the public health insurance program. HHS plans to open a special enrollment period so these individuals can apply for coverage through the Affordable Care Act.

CNBC Health & Science

Read CNBC’s latest global health coverage:

Although Covid vaccines and treatments will remain free for everyone after the public health emergency ends, this may change for uninsured adults when the federal stockpile runs out.

The Biden administration plans to stop buying vaccines and treatments for the public as early as this fall in part because Congress has not appropriated additional funding. When the federal government pulls out, vaccines and treatments will be purchased and distributed through the private market.

This means Pfizer and Moderna will sell the shots directly to health-care providers and whether you pay will depend on whether you are insured.

People with insurance through the Affordable Care Act and Medicare will still get the shots for for free. Those on Medicaid will get the shots for free through September 2024, after which coverage will vary from state to state.

Adults who are uninsured will likely have to pay for the shots when the stockpile runs out, though the White House has said it’s developing plans to help them.



Source

Trump’s pharmaceutical tariff threat loses bite after Pfizer deal reassures drugmakers
Health

Trump’s pharmaceutical tariff threat loses bite after Pfizer deal reassures drugmakers

U.S. President Donald Trump shakes hands with Pfizer CEO Albert Bourla (L) as he announces a deal with Pfizer to lower Medicaid drug prices in the Oval Office of the White House on September 30, 2025 in Washington, DC. Win Mcnamee | Getty Images President Donald Trump’s long-awaited threat to impose pharmaceutical tariffs may not […]

Read More
Healthy Returns: Pfizer’s new obesity bet, Metsera, releases encouraging data on lead drug
Health

Healthy Returns: Pfizer’s new obesity bet, Metsera, releases encouraging data on lead drug

Thomas Fuller | SOPA Images | Lightrocket | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Pfizer‘s newest bet on obesity is already showing promise.  The company last week said it would buy […]

Read More
Trump, Pfizer to announce agreement to lower Medicaid drug prices
Health

Trump, Pfizer to announce agreement to lower Medicaid drug prices

U.S. President Donald Trump speaks during a press conference in the Roosevelt Room at the White House in Washington, D.C., U.S., May 12, 2025. Nathan Howard | Reuters President Donald Trump on Tuesday will announce an agreement with Pfizer to voluntarily sell its medications for less, as his administration pushes to link U.S. drug prices […]

Read More